Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 30.2441.3214.2638.52736.19

What is the latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA is 30.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202530.24
Mar202441.32
Mar202314.26
Mar202238.52
Mar2021736.19

How is Price to Cash Earnings (PCE) of ORCHID PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 30.24
-26.82
Mar2024 41.32
189.76
Mar2023 14.26
-62.98
Mar2022 38.52
-94.77
Mar2021 736.19 -

Other Financial Ratios of ORCHID PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,615.4 Cr 1% -5.7% -53.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,752.0 Cr 0.7% -0.7% -13.1% Stock Analytics
DIVIS LABORATORIES ₹160,626.0 Cr 0.6% -1.9% 10.9% Stock Analytics
CIPLA ₹125,951.0 Cr -0.1% -0.3% -6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,932.0 Cr -1% -3% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹109,414.0 Cr 0.6% 3.7% -1.6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

1%

-5.7%

-53.7%

SENSEX

1.6%

2.6%

-0.3%


You may also like the below Video Courses